Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Spinal Muscular Atrophy Clinical Trials

85 recruiting trials for Spinal Muscular Atrophy. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
85
Total Trials
85
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07478172

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults with neuromuscular...

Sponsor: University of Missouri-ColumbiaEnrolling: 501 location
RECRUITINGNCT06310421

Spinal Muscular Atrophy Neonatal Screening Program

Spinal muscular atrophy (SMA) is a group of disorders caused by the degeneration of the motor neuron cells of the anterior horn of the spinal cord and, in some subtypes, of the...

Sponsor: IRCCS Burlo GarofoloEnrolling: 115002 locations
RECRUITINGNCT06756633

Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases

The clinical trial titled "Investigation of Respiratory Functions, Thoracoabdominal Movements, and Exercise Capacity in Neuromuscular Diseases" aims to evaluate the respiratory...

Sponsor: Lokman Hekim UniversityEnrolling: 421 location
RECRUITINGPhase 3NCT07221669

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in...

In this study, researchers will learn more about the effects and safety of BIIB115, also known as salanersen. Specifically, researchers will learn more about how salanersen works...

Sponsor: BiogenEnrolling: 302 locations
RECRUITINGNCT05724173

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 32 locations
RECRUITINGNCT05789758

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before...

In this study, researchers will know more about the effects of nusinersen, also known as Spinraza®, in pregnant participants with spinal muscular atrophy, also known as SMA. This...

Sponsor: BiogenEnrolling: 2014 locations
RECRUITINGNCT06562283

Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease caused by the degeneration of motor neurons in the anterior horn of the spinal cord, due to the...

Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 804 locations
RECRUITINGNCT07286565

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal...

The Active NBS Liege study is a monocentric, academic, fully remote, observational study designed to validate digital measures of motor development in children with spinal...

Sponsor: Centre Hospitalier Universitaire de LiegeEnrolling: 1001 location
RECRUITINGNCT05638750

Outpatient Rehabilitation Intervention for Young Children With SMA

An outpatient rehabilitation program for children (6 months to less than 6 years old) with Spinal Muscular Atrophy (SMA) treated with genetic based therapies is being studied....

Sponsor: Holland Bloorview Kids Rehabilitation HospitalEnrolling: 101 location
RECRUITINGNCT03489278

Clinical Procedures to Support Research in ALS

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called...

Sponsor: University of MiamiEnrolling: 120011 locations
RECRUITINGNCT04292574

UK SMA Patient Registry

Spinal muscular atrophy (SMA) is a form of motor neuron disease, most commonly caused by a mutation in the survival motor neuron 1 gene (SMN1) which results in a wide disease...

Sponsor: Newcastle UniversityEnrolling: 8001 location
RECRUITINGNCT07400198

Gait and Bone Health in SMA

The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that...

Sponsor: Jacqueline MontesEnrolling: 221 location
RECRUITINGNCT06019637

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

A long-term safety study in Brazilian patients with a confirmed diagnosis of Spinal Muscular Atrophy (SMA) treated with Onasemnogene Abeparvovec (Zolgensma®)

Sponsor: Novartis PharmaceuticalsEnrolling: 502 locations
RECRUITINGNCT00874783

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Human fibroblasts and possibly other human somatic cells may be reprogrammed into induced pluripotent stem (iPS) cells by the forced expression of transcription factors (1-5). The...

Sponsor: Hadassah Medical OrganizationEnrolling: 1201 location
RECRUITINGNCT05768048

Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments

This is an observational multicenter retrospective and prospective study on natural history of SMA also considering the 'new natural history' secondary to the availability of...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 5005 locations
RECRUITINGNCT03940911

Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis

Axial spondyloarthropathy (SpA) is the most common inflammatory rheumatism (1% of the general population) with important medico-economic consequences. Fatigue is a major feature...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 1221 location
RECRUITINGNCT00912041

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 275 locations
RECRUITINGNCT06322654

A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal...

A head-to-head study comparing the functional value of two models of robotically assisted rehabilitation in patients with SMA. A single-center, randomized, single-blinded,...

Sponsor: Wiktor Dega University Orthopedic and Rehabilitation HospitalEnrolling: 2001 location
RECRUITINGPhase 3NCT07265232

Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle...

The study objective is to determine the real-world safety and effectiveness of Vesemnogene lantuparvovec for the treatment of SMA. The specific objectives are: * To determine...

Sponsor: Lantu BiopharmaEnrolling: 151 location
RECRUITINGPhase 4NCT05861999

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular...

This is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered in pediatric participants with SMA and 2 SMN2...

Sponsor: Hoffmann-La RocheEnrolling: 2819 locations
RECRUITINGNCT05755451

Natural History of SMA

This is an investigator initiated observational study with the aim to record several aspects of function, care and adverse events in a large cohort of SMA patients followed...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 12005 locations
RECRUITINGNCT06437392

Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

The purpose of the study is identify the prevalence of sarcopenia and its associated factors in patients with psoriatic arthritis. Furthermore, we aimed to investigate the...

Sponsor: Ankara City Hospital BilkentEnrolling: 1021 location
RECRUITINGNCT04177134

French Register of Patients With Spinal Muscular Atrophy

The primary objectives of the study are to obtain clinically meaningful data on survival and outcomes of all the patients with spinal muscular atrophy (SMA) 5q types 1 through 4...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 10001 location
RECRUITINGNCT06839469

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural...

Sponsor: Columbia UniversityEnrolling: 1063 locations
RECRUITINGNCT06194539

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: 1. Complete online...

Sponsor: Bar-Chama, Natan, M.D.Enrolling: 751 location
RECRUITINGNCT06147414

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Cell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free DNA (cfDNA) in...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 5501 location
RECRUITINGNCT06955897

Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA

The purpose of this project is to investigate the utility of the SMA EFFORT, an SMA-specific patient-reported outcome measure, to assess perceived physical fatigability that is...

Sponsor: Columbia UniversityEnrolling: 451 location
RECRUITINGPhase 2NCT06290713

Vasodilator and Exercise Study for DMD (VASO-REx)

Examining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve...

Sponsor: University of FloridaEnrolling: 501 location
RECRUITINGNCT03698149

ECoG BMI for Motor and Speech Control

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

Sponsor: Karunesh GangulyEnrolling: 31 location
RECRUITINGNCT07488338

HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness

This single-arm pilot study will assess the preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in...

Sponsor: Teachers College, Columbia UniversityEnrolling: 201 location
RECRUITINGNCT07231549

CuidAME: Longitudinal Data Collection From Patients With Spinal Muscular Atrophy in Spain

The goal of this observational study is to set up a longitudinal data collection study to perform a long-term follow-up of SMA patients in a real-world setting, and to standardise...

Sponsor: Fundació Sant Joan de DéuEnrolling: 10001 location
RECRUITINGPhase 1 / Phase 2NCT06421831

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

The study will evaluate safety and efficacy of intrathecal delivery of GC101 gene therapy drug as a treatment of spinal muscular atrophy Type 3 (SMA 3) patients.

Sponsor: GeneCradle IncEnrolling: 211 location
RECRUITINGNCT05726591

Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement...

Background: People with cerebral palsy, spina bifida, muscular dystrophy, or spinal cord injury often have muscle weakness and problems controlling how their legs move. This can...

Sponsor: National Institutes of Health Clinical Center (CC)Enrolling: 441 location
RECRUITINGPhase 2NCT07287982

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous...

This study aims to find the correct dose of ARGX-119 for children with SMA. The study will also look at how safe the study drug is, how well it works, how it moves through the...

Sponsor: argenxEnrolling: 6017 locations
RECRUITINGNCT04708431

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen...

Background: Androgen effects in humans are usually (but not always) mediated by the androgen receptor which is coded for by the androgen receptor gene (AR gene). Androgen...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 6501 location
RECRUITINGPhase 2NCT06365788

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

This study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 536 locations
RECRUITINGNCT03555578

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar...

The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy...

Sponsor: TakedaEnrolling: 18901 location
RECRUITINGNCT07223489

Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the...

Evaluate the diagnostic journey, patient experience, and disparities in the treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System.

Sponsor: Medstar Health Research InstituteEnrolling: 2001 location
RECRUITINGPhase 3NCT05335876

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

This is a global, prospective, multi-center study that is designed to assess the long-term safety and efficacy of OAV101 in patients who participated in an OAV101 clinical trial....

Sponsor: Novartis PharmaceuticalsEnrolling: 17520 locations
RECRUITINGPhase 1 / Phase 2NCT05824169

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

The study will evaluate safety and efficacy of intrathecal delivery of GC101 gene therapy drug as a treatment of spinal muscular atrophy Type 1 (SMA 1) patients.

Sponsor: GeneCradle IncEnrolling: 184 locations
RECRUITINGNCT07254988

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

Both GIP and GLP-2 reduce bone resorption (measured as CTX) in healthy adult individuals. In this study, we will investigate whether GIP and GLP-2 reduce CTX in children with...

Sponsor: University of CopenhagenEnrolling: 81 location
RECRUITINGNCT06363357

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients...

The goal of this clinical trial is to investigate the effect of a muscle-mimicking, fabric-type shoulder orthosis on functional movements of the upper limb in patients with...

Sponsor: Seoul National University HospitalEnrolling: 301 location
RECRUITINGNCT06998134

Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults

People with cerebral palsy (CP), muscular dystrophy (MD), spina bifida, or spinal cord injury often have muscle weakness, and problems moving their arms and legs. The NIH designed...

Sponsor: National Institutes of Health Clinical Center (CC)Enrolling: 231 location
RECRUITINGNCT06577350

Osteosarcopenia in Axial Spondyloarthritis

Axial spondyloarthritis is a chronic inflammatory disease affecting the spine, sacroiliac joints, entheses, and sometimes peripheral joints with a close link to HLAB27. Typical...

Sponsor: Ankara UniversityEnrolling: 971 location
RECRUITINGNCT05663008

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Motor neuron disease (MND) or ALS is a nervous system disease. ALS leads to a loss of movement ability that eventually leads to death. At the moment, there is no known treatment...

Sponsor: University of Dublin, Trinity CollegeEnrolling: 4001 location
RECRUITINGPhase 1 / Phase 2NCT06288230

An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy

This is an interventional study to evaluate safety and efficacy of AAV-hSMN1 in spinal muscular atrophy patients.

Sponsor: Lantu BiopharmaEnrolling: 201 location
RECRUITINGNCT06396325

A Registry Based Randomized-Controlled Trial of an Upper Limb Exergaming Intervention for Children and Adolescents With...

This is a multisite randomized controlled registry-based trial to evaluate the efficacy of an 8-week home-based exergaming intervention as compared to usual care on occupational...

Sponsor: Maryam Oskoui, MD, MSc, FRCPC, FAANEnrolling: 225 locations
RECRUITINGNCT06666816

Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases

This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore,...

Sponsor: IRCCS Eugenio MedeaEnrolling: 1202 locations
RECRUITINGNCT05204017

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to...

Sponsor: University of AlbertaEnrolling: 1504 locations
RECRUITINGNCT06978985

Adult SMA Research and Clinical Hub

Adult SMA REACH is a data collection study aiming to gain a better understanding of the impact of standards of care and new treatments on the natural history of Spinal Muscular...

Sponsor: Newcastle-upon-Tyne Hospitals NHS TrustEnrolling: 60018 locations

Showing 50 of 85 trials.Search all Spinal Muscular Atrophy trials